Article
Comprehensive circRNA Expression Profile and Transcriptomics-Based Molecular Pathway Analysis of the Sodium-Glucose Co-Transporter-2 Inhibitor Dapagliflozin in Diabetic Tubular Epithelial Cells
2021-08-03
Abstract excerpt
Diabetic kidney disease (DKD) is a serious diabetes complication. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are novel anti-diabetes drugs and have clinical renal protection. However, the molecular mechanisms involved remain unclear. Here, human proximal tubular epithelial cells (PTECs) were treated with normal glucose (NG), high glucose (HG), and three types of anti-diabetes agents including SGLT2i (dapag...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a58a1ef6-bf71-5ce1-ac6e-3a83bbd8403e
- DOI
- 10.21203/rs.3.rs-763466/v1
